JPWO2018200656A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2018200656A5
JPWO2018200656A5 JP2019557833A JP2019557833A JPWO2018200656A5 JP WO2018200656 A5 JPWO2018200656 A5 JP WO2018200656A5 JP 2019557833 A JP2019557833 A JP 2019557833A JP 2019557833 A JP2019557833 A JP 2019557833A JP WO2018200656 A5 JPWO2018200656 A5 JP WO2018200656A5
Authority
JP
Japan
Prior art keywords
adjuvant
hemolytic
activity
resulting
present application
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019557833A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020517686A5 (https=
JP2020517686A (ja
JP7177082B2 (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/029333 external-priority patent/WO2018200656A1/en
Publication of JP2020517686A publication Critical patent/JP2020517686A/ja
Publication of JPWO2018200656A5 publication Critical patent/JPWO2018200656A5/ja
Publication of JP2020517686A5 publication Critical patent/JP2020517686A5/ja
Application granted granted Critical
Publication of JP7177082B2 publication Critical patent/JP7177082B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019557833A 2017-04-25 2018-04-25 トリテルペンサポニン類似物 Active JP7177082B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201762489572P 2017-04-25 2017-04-25
US62/489,572 2017-04-25
US201762492608P 2017-05-01 2017-05-01
US62/492,608 2017-05-01
PCT/US2018/029333 WO2018200656A1 (en) 2017-04-25 2018-04-25 Triterpene saponin analogues

Publications (4)

Publication Number Publication Date
JP2020517686A JP2020517686A (ja) 2020-06-18
JPWO2018200656A5 true JPWO2018200656A5 (https=) 2022-07-20
JP2020517686A5 JP2020517686A5 (https=) 2022-07-20
JP7177082B2 JP7177082B2 (ja) 2022-11-22

Family

ID=63918684

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019557833A Active JP7177082B2 (ja) 2017-04-25 2018-04-25 トリテルペンサポニン類似物

Country Status (5)

Country Link
US (1) US20200164065A1 (https=)
EP (1) EP3615039A4 (https=)
JP (1) JP7177082B2 (https=)
CN (1) CN110730666A (https=)
WO (1) WO2018200656A1 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3003483C (en) 2015-11-06 2022-09-13 Adjuvance Technologies, Inc. Triterpene saponin analogues
EP3618836A4 (en) 2017-04-25 2021-01-13 Adjuvance Technologies, Inc. TRITERPENSAPONINALOGA
WO2019079160A1 (en) 2017-10-16 2019-04-25 Adjuvance Technologies, Inc. TRITERPENIC SAPONIN ANALOGS
CA3157372A1 (en) * 2019-11-05 2021-05-14 Adjuvance Technologies, Inc. Varicella zoster
US20230128815A1 (en) * 2020-03-23 2023-04-27 Adjuvance Technologies, Inc. Adjuvant compounds, salt forms, and formulations
WO2021236809A2 (en) 2020-05-19 2021-11-25 Othair Prothena Limited Multi-epitope vaccine for the treatment of alzheimer's disease
KR20230080397A (ko) 2020-08-07 2023-06-07 오타이르 프로테나 리미티드 알츠하이머 질환을 치료하기 위한 멀티에피토프 백신
EP4323377A4 (en) * 2021-04-14 2025-04-23 Adjuvance Technologies, Inc. Vaccines
US20250025550A1 (en) * 2021-11-08 2025-01-23 Adjuvance Technologies, Inc. Adjuvant compounds and formulations
EP4190359A1 (en) 2021-12-03 2023-06-07 Asociación Centro de Investigación Cooperativa en Biociencias - CIC bioGUNE Saponin-based adjuvants and vaccines
WO2023139145A1 (en) 2022-01-19 2023-07-27 Asociación Centro De Investigación Cooperativa En Biociencias-Cic Biogune Saponin-based adjuvants and vaccines
CN117106004A (zh) * 2022-05-17 2023-11-24 北京科兴中维生物技术有限公司 三萜皂苷化合物及其制备方法及应用
WO2024218268A1 (en) 2023-04-20 2024-10-24 Asociación Centro De Investigación Cooperativa En Biociencias-Cic Biogune Saponin derivatives as adjuvants and photoaffinity probes

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0504436D0 (en) * 2005-03-03 2005-04-06 Glaxosmithkline Biolog Sa Vaccine
CA2708716A1 (en) * 2007-12-21 2009-07-02 Glaxosmithkline Biologicals S.A. Vaccines for malaria
JP5706815B2 (ja) * 2008-04-08 2015-04-22 スローン − ケタリング・インスティテュート・フォー・キャンサー・リサーチ トリテルペンであるサポニン、その合成法および使用
SI2271360T1 (sl) * 2008-04-16 2015-12-31 Glaxosmithkline Biologicals S.A. Cepivo
CN112028951A (zh) 2014-05-30 2020-12-04 索隆-基特林癌症研究协会 微小皂苷类似物、合成及其用途
CA3003483C (en) 2015-11-06 2022-09-13 Adjuvance Technologies, Inc. Triterpene saponin analogues

Similar Documents

Publication Publication Date Title
JPWO2018200656A5 (https=)
PH12021552782A1 (en) Modulators of thr-㟠and methods of use thereof
CN111212846B (zh) 三萜皂苷类似物
EP4344743A3 (en) Heterocyclic flavone derivatives, compositions, and methods related thereto
EP4442241A3 (en) Retinol replacement in skin treatment
CA2083274C (en) The pharmacological use of certain cystine derivatives
CL2022002481A1 (es) Compuestos antivirales y métodos para la administración de los mismos
CY1115484T1 (el) Ενωσεις, συνθεσεις και μεθοδοι για την θεραπεια αμυλοειδικων ασθενειων και συνουκλεϊνοπαθειων, οπως νοσος alzheimer, διαβητης τυπου 2 και νοσος parkinson
US20060264353A1 (en) Prostaglandin f2alpha analogs and their use in combination with antimicrobial proteins for the treatment of glaucoma and intraocular hypertension
AR060974A1 (es) Compuesto de 4-piridinona, su uso para la preparacion de un medicamento, composicion farmaceutica que lo comprende, proceso para su preparacion y proceso para la preparacion de un compuesto intermediario de utilidad en el anterior
RU2016134425A (ru) Стабильные аналоги глюкагона и их применение для лечения гипогликемии
MY199821A (en) Modified lipidated relaxin b chain peptides and their therapeutic use
CO6410283A2 (es) Métodos para administrar (4ar,10ar)-1-n-propil-1,2,3,4,4a,5,10,10a-octahidro-benzo[g]quinolin-6,7-diol y compuestos relacionados a través de la mucosa oral, la mucosa nasal o la piel, y sus compoisiciones farmacéuticas
NZ594184A (en) Skin treatment
PH12021550617A1 (en) Cyclic dinucleotide analogue, pharmaceutical composition thereof, and application
BR112022020956A2 (pt) Análogos de peptídeo tirosina tirosina (pyy) de ação prolongada e métodos de uso
BR0317519A (pt) Composição farmacêutica para anestesia local e uso da mesma
RU2012153186A (ru) Каротиноидное солнцезащитное средство
MX2022013398A (es) Compuestos de tetrahidroisoquinolina como activadores de nrf2.
RU2006117208A (ru) Применение частей опунции и/или экстрактов из нее для лечения депрессий
MX2021005776A (es) Formulaciones farmaceuticas para administracion subcutanea.
CN107847452A (zh) 应答选择性C5a激动剂EP67的构象稳定类似物
SA522441781B1 (ar) Tlr4 مادة مساعدة ذات نشاط معضد لـ
De et al. Spilanthol (affinin)
PY2189412A (es) Compuestos y composiciones para el tratamiento de la criptosporidiosis